How does it work?

Following a 25-minute panel, you will work in small groups to discuss a question posed by the speakers.

• Now that data access is no longer the primary bottleneck, how can pharma turn unstructured data into insights that directly improve HCP engagement?
• How can the AI capabilities within existing CRM platforms be used to translate data into more relevant, timely and personalised customer interactions?
• How can engagement insights generated through CRM be converted into actions, content and next-best interactions that resonate with HCPs?
• What does "good" commercial data architecture look like today, and how does maturity vary across the pharma sector?
• When does it make sense for pharma organisations to build or augment their own proprietary commercial data assets?
• How should leaders decide when to build versus buy when it comes to CRM, data platforms and commercial insight capabilities?